SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharma informs about outcome of board meeting

24 Feb 2018 Evaluate

With reference to the subject cited, it is hereby informed that the Board of Directors of Vista Pharma at the meeting held on February 24, 2018 at the Corporate office of the Company, considered and approved the appointment of Chakravarthula Divya Bhavani, as Additional Director (Non- Executive, Independent) on the Board of the Company.

The above information is a part of company’s filings submitted to BSE.

Vista Pharmaceutical Share Price

7.48 0.00 (0.00%)
16-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1950.00
Dr. Reddys Labs. 1223.90
Cipla 1429.45
Lupin 2500.05
Zydus Lifesciences 1153.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: